Back to Results
First PageMeta Content
Ammine complexes / Eli Lilly and Company / Carboplatin / Cisplatin / Prostate cancer / Chemotherapy regimens / Docetaxel / Lung cancer / Satraplatin / Chemistry / Medicine / Alkylating antineoplastic agents


Open Document

File Size: 222,75 KB

Share Result on Facebook

City

San Francisco / Dallas / Florence / /

Company

Hercules / Vora SA / Bristol-Myers Squibb / /

/

Event

FDA Phase / /

Facility

University of Texas Southwestern Medical Center / Vanderbilt University / /

/

IndustryTerm

pharmaceutical industry / personal communications / cancer therapy / stable / treatment of lung cancer / venous access devices / Treatment of Cancer / treatment of various cancers / carrier ligand specificity / designed platinum products / /

MedicalCondition

recurrent ovarian cancer / ovarian cancer / subcutaneous human bresat tumors / lymphocytopenia / inoperable non-small-cell lung cancer / colorectal cancer / human cervical squamous cell carcinoma / Refractory Cancer / plasmacytoma / human tumor / extreme thrombocytopenia / nausea / thrombocytopenia / small cell lung cancer / J Cancer / Other tumor / central nervous system tumors / colon cancer / melanoma / small-cell lung cancer / SCLC / febrile neutropenia / non-small-cell lung cancer / recurrent squamous cell carcinoma / taxane-resistant tumors / non-small cell lung cancer / diarrhea / esophageal cancer / resistant human ovarian carcinoma / head and neck cancer / several human cancer / prostate cancer / epithelial ovarian cancer / hormone-refractory prostate cancer / human ovarian cancer / advanced hormone-resistant prostate cancer / cancers / tumor / advanced prostate cancer / squamous cell carcinoma / measurable disease / Cancer / NSCLC / antitumor drug screen panel representing leukemia / human lung cancer / localized cancer / cervical cancer / human ovarian carcinoma / non-smallcell lung cancer / neutropenia / tumour / extensivestage small cell lung cancer / Partial tumor / vomiting / pain / lung cancer / tested tumor / refractory prostate cancer / stable disease / III nonsmall-cell lung cancer / murine tumor / cisplatin-sensitive small cell lung cancer / objective tumor / advanced refractory prostate cancer / prostate carcinoma / nonmetastatic squamous cell carcinoma / /

MedicalTreatment

radiation therapy / Combination chemotherapy / chemotherapy / radiotherapy / radiation / cancer therapy / prostatectomy / cisplatin chemotherapy / CCR / /

MusicGroup

Nausea / /

Organization

National Cancer Institute / University of Texas Southwestern Medical Center / Dallas / Food and Drug Administration / i.v. administration / European Organization for Research and Treatment of Cancer / American Society of Clinical Oncology / Moncrief Radiation Oncology Center / Department of Radiation Oncology / Vanderbilt University / International Chemotherapy Society / American Association for Cancer Research / AACR Publications Department / /

Person

Huang J. Is / Min Yao Clin / Ann Oncol / /

/

Position

RT / cancer and squamous cell head / /

Product

JM216 / carboplatin / Herceptin / cisplatin / etoposide / paclitaxel / prednisone / fluorouracil / mitoxantrone / JM / JM-216 / /

ProvinceOrState

Texas / California / /

PublishedMedium

Cancer Research / /

RadioStation

Mauer AM / /

Technology

radiation / DNA binding / apoptosis / pharmacokinetics / chemotherapy / treating cancer / drug development / /

URL

www.aacrjournals.org / http /

SocialTag